I welcome the U.S. Senate investigation into monopolistic drug manufacturers who commit unconscionable price gouging on GLP-1 medications. These global companies are reaping enormous profits that exponentially outweigh the costs to make them. The North Carolina State Health Plan cannot double the individual premiums for over 500,000 state employees for the prescription of one drug to 25,000 people.
Treasurer Dale R. Folwell, CPA, and the North Carolina Supplemental Retirement Plans Board of Trustees (Board) unanimously approved a 12-month waiver of its administrative fee at the regularly scheduled quarterly Board meeting held on Feb. 22, saving NC 401(k) Plan and NC 457 Plan (Plans) participants approximately $1.6 million over the next year.